LAIYANG, China, Jan. 17, 2008 (PRIME NEWSWIRE) -- Genesis Pharmaceuticals
Enterprises, Inc. (OTCBB:GTEC) ("Genesis" or the "Company"), a leading
pharmaceutical company in the People's Republic of China, today announced that
the Company and its CEO received several awards and recognition from the city
and province in which the Company is located.

The Company was recognized as 'One of the Top Tax Paying Enterprises in 2007' by
Laiyang City (Laiyang City is located in Yantai City), Shandong province, which
is one of China's most dynamic commercial regions. In recognition of its
business success and the high quality of its products, Genesis was nominated by
the government of Laiyang City to be on the list of 'Top 100 Enterprises in
Yantai City 2007.' The Company was awarded 2008 membership on the distinguished
China Science Technology Investment Association under the State Planning and
Development Commission.

Genesis' CEO, Mr. Wubo Cao, was selected to be a representative to the People's
Congress of Yentai for a five-year term, through 2013. Mr. Cao also serves as a
board member for the China Science Technology Investment Association under the
State Planning and Development Commission, and Deputy Chairman for both the
Laiyang Consumer and the Industrial and Commerce Associations.

At Laiyang's '2007 Year-End Economy Overview Conference,' the Mayor of Laiyang,
Mr. Guoqiang Yang, commented, "Genesis Pharmaceuticals and Mr. Wubo Cao are
great assets to the city of Yantai and Shandong Province. Mr. Cao is a person of
great integrity with excellent leadership skills. His career is an inspiration
to young entrepreneurs throughout China, and I am confident that Genesis'
shareholders appreciate his ability to build a public company benefiting
investors, stakeholders and employees. Mr. Cao is dedicated to making Genesis a
successful pharmaceutical company."

In response to the awards and recognition received by himself and Genesis, Mr.
Cao said, "I am grateful for support from and recognition by city and provincial
government officials. Genesis is committed to our shareholders, and I look
forward to visiting the United States, where I will personally meet with many of
Genesis' Wall Street and Main Street supporters."

About Genesis Pharmaceuticals Enterprises

Genesis Pharmaceutical Enterprises, Inc. is engaged in the research,
development, production, marketing and sales of pharmaceutical products in the
People's Republic of China. Its operations are located in Northeast China in an
Economic Development Zone in Laiyang City, Shandong province. Genesis produces
tablets, capsules, and granules for both western and Chinese herbal-based
medical drugs. The Company maintains a representative office in the United
States.

Safe Harbor Statement

Certain statements set forth in this press release constitute "forward-looking
statements." Such statements are not guarantees of future performance and are
subject to risks and uncertainties that could cause the Company's actual results
and financial position to differ materially from those included within the
forward-looking statements. Forward-looking statements involve risks and
uncertainties, including those relating to the Company's ability to introduce,
manufacture and distribute new drugs. Actual results may differ materially from
anticipated or predicted results, and reported results should not be considered
as an indication of future performance. The potential risks and uncertainties
include, among others, the Company's ability to obtain raw materials needed in
manufacturing, the continuing employment of key employees, the failure risks
inherent in testing any new drug, the possibility that regulatory approvals may
be delayed or become unavailable, patent or licensing concerns that may include
litigation, direct competition from other manufacturers and product
obsolescence. More information about the potential factors that could affect the
Company's business and financial results is included in the Company's filings,
available via the United States Securities and Exchange Commission.

-0-
CONTACT:  Genesis Pharmaceuticals Enterprises, Inc.
          Ms. Elsa Sung, CFO
          (877) 895-3650 ext 701
          genesispharm@gmail.com

          CCG Elite Investor Relations, Inc.
          Mr. Crocker Coulson, President
          +1-646-213-1915 (New York)
          crocker.coulson@ccgir.com